Cargando…
Tocilizumab Effect on Lipid Profile in Correlation to Cardiovascular Events: A Retrospective Cohort Study
OBJECTIVE: To study the effect of tocilizumab initiation on the lipid profile, in correlation to a composite of any cardiovascular events. METHODS: A retrospective cohort study, using data from the King Faisal Specialist Hospital & Research Centre database, from January 2014 to December 2019. Pa...
Autores principales: | Alsulaim, Toka, Alhassan, Noor, Khalil, Hala, Almutlaq, Abdullah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378990/ https://www.ncbi.nlm.nih.gov/pubmed/34422057 http://dx.doi.org/10.1155/2021/5535486 |
Ejemplares similares
-
Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021) -
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study
por: Danese, Mark D, et al.
Publicado: (2017) -
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016) -
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020) -
Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)